Predialysis systolic blood pressure evolution in incident hemodialysis patients: Effects of the dry weight method and prognostic value

Blood Purification

Volumn 33, Issue 4, 2012, Pages 275-283

  Chazot, Charles ^a,b   Vo Van, Cyril ^a,b   Deleaval, Patrik ^a,b   Lorriaux, Christie ^a,b   Hurot, Jean Marc ^a,b   Mayor, Brice ^a,b   Jean, Guillaume ^a,b  

^a NephroCare Tassin Charcot   (France)

^b NONE   (France)

Author keywords

Blood pressure; Dry weight; Hemodialysis; Hypertension; Incident patients; Mortality; Reverse epidemiology

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; LOOP DIURETIC AGENT;

AGED; ARTICLE; BLOOD PRESSURE MEASUREMENT; BODY WEIGHT; CLINICAL EVALUATION; COMORBIDITY; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DRY WEIGHT METHOD; FEMALE; HEART ARRHYTHMIA; HEART FAILURE; HEMODIALYSIS PATIENT; HUMAN; HYPERTENSION; INCIDENT HEMODIALYSIS PATIENT; LIVER FAILURE; MAJOR CLINICAL STUDY; MALE; MORTALITY; NEOPLASM; PRIORITY JOURNAL; PROCEDURES; PROGNOSIS; RESPIRATORY FAILURE; RISK ASSESSMENT; SODIUM RESTRICTION; SURVIVAL; SYSTOLIC BLOOD PRESSURE; VALVULAR HEART DISEASE; VASCULITIS;

EID: 84860853941     PISSN: 02535068     EISSN: 14219735     Source Type: Journal    
DOI: 10.1159/000337101     Document Type: Article

References (33)

1. Davenport A, Cox C, Thuraisingham R: Achieving blood pressure targets during dialysis improves control but increases intradialytic hypotension. Kidney Int 2008; 73: 759-764.
2. Goodkin DA, Young EW, Kurokawa K, et al: Mortality among hemodialysis patients in Europe, Japan, and the United States: casemix effects. Am J Kidney Dis 2004;44(suppl 2):16-21.
3. Charra B, Calemard E, Ruffet M, et al: Survival as an index of adequacy of dialysis. Kidney Int 1992; 41: 1286-1291.
4. Foley RN, Parfrey PS, Harnett JD, et al: Impact of hypertension on cardiomyopathy, morbidity and mortality in end-stage renal disease. Kidney Int 1996; 49: 1379-1385.
5. Port FK, Hulbert-Shearon TE, Wolfe RA, et al: Predialysis blood pressure and mortality risk in a national sample of maintenance hemodialysis patients. Am J Kidney Dis 1999; 33: 507-517.
6. Duranti E, Imperiali P, Sasdelli M: Is hypertension a mortality risk factor in dialysis? Kidney Int Suppl 1996; 55:S173-S174.
7. Kalantar-Zadeh K, Kilpatrick RD, Kopple JD: Reverse epidemiology of blood pressure in dialysis patients. Kidney Int 2005; 67: 2067-2068.
8. Salem MM: Treatment of hypertension in the hemodialysis patient: beneficial or not? Curr Hypertens Rep 2000; 2: 441-444.
9. Zager PG, Nikolic J, Brown RH, et al: 'U' curve association of blood pressure and mortality in hemodialysis patients. Medical Directors of Dialysis Clinic, Inc. Kidney Int 1998; 54: 561-569.
10. Agarwal R: Hypertension and survival in chronic hemodialysis patients-past lessons and future opportunities. Kidney Int 2005; 67: 1-13.
11. Agarwal R: Blood pressure and mortality among hemodialysis patients. Hypertension 2010; 55: 762-768.
12. Twardowski SJ: Sodium, hypertension, and an explanation of the 'lag phenomenon' in hemodialysis patients. Hemodial Int 2008; 12: 412-425.
13. Charra B, Laurent G, Chazot C, et al: Clinical assessment of dry weight. Nephrol Dial Transplant 1996; 11(suppl 2):16-19.
14. Scribner BH, Buri R, Caner JE, et al: The treatment of chronic uremia by means of intermittent hemodialysis: a preliminary report. Trans Am Soc Artif Intern Organs 1960: 6:114-122.
15. Chazot C, Charra B, Vo Van C, Jean G, Vanel T, Calemard E, Terrat JC, Ruffet M, Laurent G: The Janus-faced aspect of 'dry weight'. Nephrol Dial Transplant 1999; 14: 121-124.
16. Charra B, Bergstrom J, Scribner BH: Blood pressure control in dialysis patients: importance of the lag phenomenon. Am J Kidney Dis 1998; 32: 720-724.
17. Agarwal R, Alborzi P, Satyan S, Light RP: Dry-weight reduction in hypertensive hemodialysis patients (DRIP): a randomized, controlled trial. Hypertension 2009; 53: 500-507.
18. Töz H, Ozkahya M, Ozerkan F, et al: Improvement in 'uremic' cardiomyopathy by persistent ultrafiltration. Hemodial Int 2007; 11: 46-50.
19. Wizemann V, Schilling M: Dilemma of assessing volume state-the use and the limitations of a clinical score. Nephrol Dial Transplant 1995; 10: 2114-2117.
20. Chan CT, Harvey PJ, Böger R, et al: Dissociation between the short-term effects of nocturnal hemodialysis on endothelium dependent vasodilation and plasma ADMA. Arterioscler Thromb Vasc Biol 2005; 25: 2685-2686.
21. Wabel P, Moissl U, Chamney P, et al: Towards improved cardiovascular management: the necessity of combining blood pressure and fluid overload. Nephrol Dial Transplant 2008; 23: 2965-2971.
22. Chazot C, Vo-Van C, Zaoui E, et al: Fluid overload correction and cardiac history influence brain natriuretic peptide evolution in incident haemodialysis patients. Nephrol Dial Transplant, 2011.
23. Movilli E, Gaggia P, Zubani R, et al: Association between high ultrafiltration rates and mortality in uraemic patients on regular haemodialysis. A 5-year prospective observational multicentre study. Nephrol Dial Transplant 2007; 22: 3547-3552.
24. Saran R, Bragg-Gresham JL, Levin NW, et al: Longer treatment time and slower ultrafiltration in hemodialysis: associations with reduced mortality in the DOPPS. Kidney Int 2006; 69: 1222-1228.
25. Flythe JE, Kimmel SE, Brunelli SM: Rapid fluid removal during dialysis is associated with cardiovascular morbidity and mortality. Kidney Int 2011; 79: 250-257.
26. Burton JO, Jefferies HJ, Selby NM, McIntyre CW: Hemodialysis-induced repetitive myocardial injury results in global and segmental reduction in systolic cardiac function. Clin J Am Soc Nephrol 2009; 4: 1925-1931.
27. McIntyre CW: Recurrent circulatory stress: the dark side of dialysis. Semin Dial 2010; 23: 449-451.
28. Wizemann V, Wabel P, Chamney P, et al: The mortality risk of overhydration in haemodialysis patients. Nephrol Dial Transplant 2009; 24: 1574-1579.
29. Ozkahya M, Töz H, Unsal A, et al: Treatment of hypertension in dialysis patients by ultrafiltration: role of cardiac dilatation and time factor. Am J Kidney Dis 1999; 34: 218-221.
30. Kayikcioglu M, Tumuklu M, Ozkahya M, et al: The benefit of salt restriction in the treatment of end-stage renal disease by haemodialysis. Nephrol Dial Transplant 2009; 24: 956-962.
31. http://www.who.int/dietphysicalactivity/Salt-Report-VC-april07.pdf: Reducing salt intake in populations. Report of a WHO forum and technical meeting. Paris, WHO, 2006.
32. Canaud B: Residual renal function: the delicate balance between benefits and risks. Nephrol Dial Transplant 2008; 23: 1801-1805.
33. Inrig JK, Patel UD, Toto RD, Szczech LA: Association of blood pressure increases during hemodialysis with 2-year mortality in incident hemodialysis patients: a secondary analysis of the Dialysis Morbidity and Mortality Wave 2 Study. Am J Kidney Dis 2009; 54:881-890.